Background
==========

With soaring oil price but indefinitely high demand for petroleum, various sustainable forms of alternative energy and chemicals have been sought after. Microorganisms are able to utilize a wide range of substrate such as plant biomass or agricultural waste and convert them into valuable chemicals and biofuel. With rapid development in microbial engineering technology, this bio-based refinery will be more feasible in terms of cost in the future and eventually reduce the dependency on fossil fuel.

2,3-Butanediol is an interesting metabolic product as its derivatives can be used in wide arrays of industries ranging from synthetic rubber, solvents and drugs. 2,3-Butanediol can be produced efficiently via mixed acid fermentation with prokaryotes such as *Klebsiella pneumoniaKlebsiella oxytocaEnterobacter aerogenesSerratia*, and *Bacillus polymyxa*\[[@B1]\]. In these bacteria, pyruvate is first converted into α-acetolactate by acetolactate synthase. In anoxic state, α-acetolactate decarboxylase catalyzes the conversion of α-acetolactate into acetoin (Figure [1](#F1){ref-type="fig"}, green arrow). In the presence of oxygen, spontaneous decarboxylation of α-acetolactate produces diacetyl. Diacetyl reductase then converts diacetyl into acetoin. 2,3-Butanediol is resulted from the reduction of acetoin by butanediol dehydrogenase.

![**Metabolic pathways for 2,3-butanediol biosynthesis and pyruvate metabolism in*S. cerevisiae*.** Green arrow shows the bacterial 2,3-butanediol synthesis pathway through α-acetolactate decarboxylase. Blue boxes contain the *S. cerevisiae* innate genes, while yellow boxes indicate the foreign genes introduced to the engineered strains.](1475-2859-11-68-1){#F1}

Most of these bacteria, however, belong to class 2 microorganisms, which are not desirable in industrial-scale fermentation in terms of safety regulations \[[@B2]\]. The need for safe 2,3-butanediol producers are undeniably important when 2,3-butanediol are used as precursors for food additives and cosmetics. Yang et al. has successfully screened a GRAS (generally regarded as safe) microorganism *Bacillus amyloliquefaciens* B10-127 that has high yield (0.42 g·g^-1^glucose) and could produce up to 92.3 g·l^-1^ of 2,3-butanediol during fed-batch fermentation \[[@B3]\]. The model eukaryotic microorganism *Saccharomyces cerevisiae* which is widely used in the industry is also a promising host microorganism.

In *S. cerevisiae*, acetaldehyde, pyruvate and α-acetolactate are the precursors of 2,3-butanediol (Figure [1](#F1){ref-type="fig"}). The biosynthetic pathway with diacetyl as intermediate is similar with that of the bacteria's. However, α-acetolactate decarboxylase is not found in most of the S*. cerevisiae* strain. Instead, *S. cerevisiae* can synthesize acetoin via the condensation of active acetaldehyde with acetaldehyde by pyruvate decarboxylase \[[@B4]\]. In addition, the carboligase mechanism of pyruvate decarboxylase for the synthesis of acetoin from the reaction between pyruvate and acetaldehyde has been elucidated previously \[[@B5]\]. Acetoin is then converted into 2,3-butanediol by butanediol dehydrogenase.

Hitherto, there are few reports regarding 2,3-butanediol production by engineered *S. cerevisiae* strain. 2,3-Butanediol production has been favored over acetoin and diacetyl in beer and wine fermentation due to its neutral organoleptic characteristics. Diacetyl production in brewing process is undesirable due to its unpleasant flavor and its low taste threshold. Previous attempts successfully reduced the diacetyl production in brewer's yeast by expressing heterologous α-acetolactate decarboxylase from *Klebsiella terrigena* and *Enterobacter aerogenes*\[[@B6],[@B7]\]. 2,3-Butanediol which has a higher flavor threshold than diacetyl is subsequently produced as the final product. Other than that, overexpression of *GPD1* in wine yeast strains also led to increased 2,3-butanediol production \[[@B8]\]. Recently, Ehsani et al. \[[@B9]\] have shown that by the overproduction of native Bdh1p or by changing the coenzyme specificity of *BDH1* of a strain that overproduces glycerol and lacks *ALD6*, they manage to yield 0.0307 - 0.033 g·g^-1^ of 2,3-butanediol in synthetic medium that simulated standard grape juice. Nevertheless, the focus of previous attempts did not target 2,3-butanediol as the main product.

Despite possessing more than two innate pathways that led from pyruvate to 2,3-butanediol \[[@B10]\], the productivity is extremely poor in wild-type *S. cerevisiae* strain when compared with bacteria\[[@B2]\]. We believed that the capability of *S. cerevisiae* in producing 2,3-butanediol can be further improved. For this purpose, computational strain design and optimization procedures can guide researcher in seeking for the best metabolic engineering strategy that coupled product formation with cellular objective such as growth \[[@B11]\]. Several genome-scale reconstruction models of yeast have been published previously \[[@B12]-[@B15]\]. Using these constraint-based stoichiometric models of yeast, we can predict the metabolic flux redistribution in a strain caused by a genetic or an environmental perturbation by flux balance analysis (FBA) methods \[[@B16],[@B17]\].

OptKnock framework\[[@B18]\] was one of the earliest FBA-based algorithms being developed to predict gene deletion strategies for the overproduction of a target chemical while maximizing the cellular objective such as growth. Since then, this algorithm has been successfully applied to design *Escherichia coli* strain for the overproduction of lactate \[[@B19]\], malonyl-CoA \[[@B20]\] and 1,4-butanediol \[[@B21]\]. In comparison with *E. coli* stoichiometric models, the eukaryote *S. cerevisiae* models are compartmentalized and more complex in terms of its metabolic network. Constraint-based modeling approach for chemical overproduction in *S. cerevisiae* has been received with mixed opinions \[[@B22]-[@B24]\]. Kennedy et al. demonstrated a successful FBA-based design approach for the production of formic acid, a non-fermentative metabolite in yeast \[[@B25]\]. Meanwhile, Bro et al. has applied the genome-scale cell model of *S. cerevisiae* to construct a strain with 40% reduced glycerol yield and increased ethanol yield \[[@B26]\].

In this paper, we attempted to engineer *S. cerevisiae* strain for the production of 2,3-butanediol. To achieve this objective, *in silico* strain design was performed with a recently published *S. cerevisiae* genome-scale metabolic model of yeast, iMM904 \[[@B13]\]. OptKnock algorithm identified genes that have to be deleted for the overproduction of 2,3-butanediol. Based on the *in silico* prediction, we constructed a few strains with different combinations of gene deletions and quantitatively analyzed the extracellular metabolites in batch fermentations. We also evaluated whether two other strategies that would reduce by-products and increase pre-cursors of 2,3-butanediol will favor its production: 1. deletion of a NADP^ + ^dependent aldehyde dehydrogenase encoded by *ALD6* and 2. deletion of NADH dependent glycerol-3-phosphate (G3P) dehydrogenase encoded by *GPD2*. Finally, we compared the effect of the amplification of *S. cerevisiae* innate 2,3-butanediol biosynthesis pathway with the introduction of bacterial pathway to different engineered host strains.

Results and discussion
======================

*In silico* design of 2,3-butanediol producing strain using OptKnock
--------------------------------------------------------------------

The flux through butanediol dehydrogenase leading to the biosynthesis of R,R-2,3-butanediol was being considered as our bioengineering objective and biomass production as the cellular objective in OptKnock. All simulations were performed under aerobic condition with glucose as the substrate. We could not identify single reaction deletion or double reaction deletion strategy that will yield significant amount of 2,3-butanediol in iMM904 model.

As we proceeded with higher numbers of reactions for deletion, we initially obtained model C and model D with four and five target reactions respectively (Table [1](#T1){ref-type="table"}). Both models include the deletion of pyruvate dehydrogenase (PDH) complex and glutamate dehydrogenase. The former is a mitochondrial multi-protein complex that catalyzes the conversion of pyruvate to acetyl-coA with concomitant generation of NADH \[[@B27]\]. With the deletion of this reaction, more flux from the pyruvate node could be redistributed towards the bioengineering objective. However, the deletion of PDH reaction reduces NADH formation that would favor 2,3-butanediol production. Other than that, the deletion of PDH complexes required deletion of up to five genes encoding different subunits that formed the complex. The NADPH dependent glutamate dehydrogenase encoded by *GDH1*and *GDH3* genes is responsible for glutamate biosynthesis and has a vital role in ammonium metabolism in yeast. It has been reported that deletion of *GDH1* increased ethanol formation and reduced glycerol formation in wild-type strain but reduced growth \[[@B28]\]. We could not clearly interpret the other reactions predicted in model C and D as they are non-intuitive. Aspartate transaminase is an important enzyme in amino acid metabolism that catalyzes the reversible conversion of aspartate and α-ketoglutarate to glutamate and oxaloacetate. NAD kinase is responsible for the phosphorylation of NAD^+^ to NADP^+^; but the combination of *POS5* and *UTR1* genes deletion is synthetically lethal \[[@B29]\]. Meanwhile, cytidylate kinase and nucleoside diphosphate kinase are reactions in nucleotide salvage pathway, whereas thymidine phosphorylase is an enzyme in purine and pyrimidine biosynthesis pathway (Additional file [1](#S1){ref-type="supplementary-material"}(a)).

###### 

Deletion strategies suggested by OptKnock algorithm for the production of 2,3-butanediol

  **ID**   **Target reaction for knockouts\***   **Corresponding gene(s) for knockouts**   **Maximum specific growth rate (1/hr)**   **R,R-2,3-Butanediol yield (g/g glucose)**
  -------- ------------------------------------- ----------------------------------------- ----------------------------------------- --------------------------------------------
  WT       \-                                    \-                                        0.288                                     0
  A        1\. ALCD2ir:                          *ADH1, ADH4, ADH5*                        0.231                                     0.313
           2\. ALCD2irm                          *ADH3*                                                                               
           3\. ALCD2x                            *SFA1*                                                                               
  B        1\. ALCD2ir                           *ADH1, ADH4, ADH5*                        0.190                                     0.362
           2\. ALCD2x                            *SFA1*                                                                               
           3\. GTPCI                             *FOL2*                                                                               
           4\. MDH                               *MDH2*                                                                               
  C        1\. GLUDyi                            *GDH1*, *GDH3*                            0.266                                     0.151
           2\. NADK                              *UTR1, UTR2, POS5*                                                                   
           3\. NDPK3                             *YNK1*                                                                               
           4\. PDHm                              *PDB1, PDA1, LAT1, LPD1*, *PDX1*                                                     
  D        1\. ASPTA                             *AAT2*                                    0.264                                     0.151
           2\. CYTK1                             \-                                                                                   
           3\. GLUDyi                            *GDH1*, *GDH3*                                                                       
           4\. PDHm                              *PDB1, PDA1, LAT1, LPD1, PDX1*                                                       
           5\. TMDPP                             *PNP1*                                                                               

\* Additional descriptions are provided in Additional file [1](#S1){ref-type="supplementary-material"}.

The maximum specific growth rate and R,R-2,3-butanediol yield were calculated based on 10 mmol·gDCW^-1^.hr^-1^ of glucose uptake. WT stands for the complete network of iMM904 model.

By removing these reactions from the set of target reactions for knockout, we managed to obtain model A. In this model, elimination of all alcohol dehydrogenase (ADH) reactions was proposed. 2,3-Butanediol and ethanol not only share the same precursor molecules, which are pyruvate and acetaldehyde; the conversion of these precursor molecules to 2,3-butanediol and ethanol also require the input of NADH. Thus, removal of the highly active alcoholic fermentation pathway of *S. cerevisiae* may favor the production of 2,3-butanediol by increasing the supply of pyruvate, acetaldehyde and NADH. Even though this strain has a growth rate 20% lower than that of the reference strain, it is predicted to yield 0.313 g·g^-1^ glucose of 2,3-butanediol (Additional file [1](#S1){ref-type="supplementary-material"}(b)).

Another quadruple deletion mutant strain with 15% higher yield of 2,3-butanediol was also proposed as a solution. In addition to the cytosolic ADH reaction of model A, cytosolic malate dehydrogenase (*MDH2*), which converts malate to oxaloacetate with a concomitant reduction of NAD^+^, was suggested as a target reaction. This gluconeogenic reaction is subject to glucose repression. However, during simulation with iMM904 model, this flux showed negative value for glucose grown wild-type strain, suggesting that the opposite reaction is active. OptKnock might have suggested the deletion of this reaction, which competes for NADH with 2,3-butanediol. The reason for GTP cyclohydrolase deletion is unknown. Furthermore, this quadruple deletion mutant has a growth rate equal to 66% of the reference strain.

Due to the large number of reactions in the genome scale metabolic model, computational strain design with OptKnock produced some non-intuitive deletion strategies that are difficult for logical interpretation. Though, OptKnock has predicted the deletion of PDH and ADH reactions, which are highly competitive for the carbon flux to 2,3-butanediol, as our strain design strategies. Since model A and model B have higher 2,3-butanediol yields than model C and model D (Table [1](#T1){ref-type="table"}), we decided to evaluate the deletion of the ADH reaction that is required in both model A and model B.

Strain construction and microaerobic fermentations
--------------------------------------------------

To test this hypothesis provided by OptKnock, we would have to delete all the genes that are responsible for the conversion of acetaldehyde to ethanol. A total of four ADH genes, *ADH1ADH3ADH4* and *ADH5*, along with *SFA1* gene have to be disrupted. Previous report \[[@B30]\] showed that *ADH4* gene product does not contribute to ethanol production. Meanwhile, *SFA1* is known as a long-chain ADH \[[@B31]\] and formaldehyde dehydrogenase \[[@B32]\]. Therefore, our target genes for deletion were reduced to three -- *ADH1ADH3* and *ADH5.*

To identify the contribution of each gene deletion to 2,3-butanediol yield, we have constructed deletion strains with different combination of the three ADH genes (Table [2](#T2){ref-type="table"}). Shake-flask cultivations were then performed with these strains at microaerobic condition. Engineered strains took longer time (\~ 60 h) to complete fermentation than the wild-type strain (\~ 40 h). Only up to 0.04 g·l^-1^ of 2,3-butanediol (0.002 g·g^-1^) was detected in the culture of BY4742 wild-type strain. In comparison with the wild-type strain, single deletion of the major ADH gene *ADH1* reduced ethanol yield by almost half and increased 2,3-butanediol yield by up to 20.5-fold, with a 2,3-butanediol maximum titers and product yields of 0.825 g·l^-1^ and 0.041 g·g^-1^, respectively (Figure [2](#F2){ref-type="fig"} and Table [3](#T3){ref-type="table"}). The double deletion strains B2C-a1a3 (*Δadh1 Δadh3*) and B2C-a1a5 (*Δadh1 Δadh5*) produced up to 1.54 g·l^-1^ and 1.42 g·l^-1^ of 2,3-butanediol, respectively, with a 2,3-butanediol yield of 85% - 88% more than the *Δadh1* single deletion strain. Strain B2C-a1a3a5, of which three ADH isozymes encoded by *ADH1ADH3* and *ADH5* genes were deleted, achieved the highest 2,3-butanediol titer and yield among the engineered strains, up to 1.64 g·l^-1^ and 0.093 g·g^-1^. This triple deletion strain produced 73.3% lesser ethanol than wild-type strain. Consistent with previous reports \[[@B33],[@B34]\], this strain still retains its ability to produce ethanol due to residual ADH isozymes. It has higher 2,3-butanediol yield per substrate than strain B2C-a1a3 and strain B2C-a1a5 owing to the fact that up to 2.41 g·l^-1^ of residual glucose was detected at the end of fermentation.

###### 

***S. cerevisiae*strains used in this study**

  **Strain**       **Genotype**                                                                        **Reference**
  ---------------- ----------------------------------------------------------------------------------- ---------------
  BY4742           *MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0*                                                  EUROSCARF
  B2C-a1           BY4742 Δ*adh1::loxP*                                                                This study
  B2C-a1a3         BY4742 Δ*adh1::loxP* Δ*adh3::loxP*                                                  This study
  B2C-a1a5         BY4742 Δ*adh1::loxP* Δ*adh5::loxP*                                                  This study
  B2C-a1a3a5       BY4742 Δ*adh1::loxP* Δ*adh5::loxP* Δ*adh3::loxP*                                    This study
  B2C-a1a6         BY4742 Δ*adh1::loxP* Δ*ald6::loxP*                                                  This study
  B2C-a1a3a6       BY4742 Δ*adh1::loxP* Δ*ald6::loxP* Δ*adh3::loxP*                                    This study
  B2C-a1a5a6       BY4742 Δ*adh1::loxP* Δ*ald6::loxP* Δa*dh5::loxP*                                    This study
  B2C-a1a6g2       BY4742 Δ*adh1::loxP* Δ*ald6::loxP* Δ*gpd2::loxP*                                    This study
  B2C-a1a3a5a6g2   BY4742 Δ*adh1::loxP* Δ*ald6::loxP* Δ*gpd2::loxP* Δ*adh3::loxP* Δa*dh5::loxP*        This study
  B2C-SB           BY4742 p423GPD-BDH1                                                                 This study
  B2C-ABC          BY4742 p423GPD-budC pCTP-URA::TEF1p-alsS + PGK1p-budA                               This study
  B2C-a1a5-SB      BY4742 Δ*adh1::loxP* Δ*adh5::loxP* p423TEF-BDH1                                     This study
  B2C-a1a5-ABC     BY4742 Δ*adh1::loxP* Δ*adh5::loxP* p423GPD-budC pCTP-URA::TEF1p-alsS + PGK1p-budA   This study
  B2C-a1a6-SB      BY4742 Δ*adh1::loxP* Δ*ald6::loxP* p423GPD-BDH1                                     This study
  B2C-a1a6-ABC     BY4742 Δ*adh1::loxP* Δ*ald6::loxP* p423GPD-budC pCTP-URA::TEF1p-alsS + PGK1p-budA   This study

\*Genotype is described in the order of the corresponding genetic manipulations.

![**Extracellular metabolite concentrations for batch cultivation.** Concentration of **(a)** 2,3-butanediol, **(b)** ethanol, **(c)** acetate and **(d)** glycerol at the end of batch cultivation under microaerobic conditions. Plus or minus signs indicate presence or absence of the corresponding gene deletion. The first column corresponds to the wild-type strain. Error bars represent standard deviations associated with four independent experiments (except for strains B2C-a1, B2C-a1a5a6, B2C-a1a3a5a6g2, where n = 3; and for strains B2C-a1a3a5 and B2C-a1a3a6, where n = 2).](1475-2859-11-68-2){#F2}

###### 

Fermentation time, extracellular metabolite concentrations and yields for shake-flask culture under microaerobic condition

  **Strain**          **Fermentation time, hr**   **Dry cell weight, g·l**^**-1**^   **Residual glucose, g·l**^**-1**^   **Acetaldehyde**^†^**, g·l**^**-1**^   **Yield, g·g**^**-1**^**glucose**                           
  ------------------- --------------------------- ---------------------------------- ----------------------------------- -------------------------------------- ----------------------------------- ------- ------- ------- -------
  BY4742              40                          1.349                              0                                   0.118                                  0.002                               0.032   0.417   0       0.017
  B2C-a1^‡^           56                          0.787                              0                                   0.663                                  0.041                               0.225   0.243   0.016   0.02
  B2C-a1a3            54                          0.876                              0                                   1.194                                  0.076                               0.254   0.166   0.012   0.029
  B2C-a1a5            72                          0.634                              1.80                                1.106                                  0.079                               0.295   0.123   0.010   0.024
  B2C-a1a3a5^†^       54                          0.900                              2.41                                1.316                                  0.093                               0.238   0.131   0.008   0.025
  B2C-a1a6            57                          0.740                              0.09                                0.493                                  0.046                               0.265   0.231   0.010   0.002
  B2C-a1a3a6^†^       63                          0.619                              0.78                                0.312                                  0.023                               0.125   0.318   0.011   0
  B2C-a1a5a6^‡^       54                          0.842                              0                                   0.263                                  0.033                               0.247   0.259   0.011   0
  B2C-a1a3a5a6g2^‡^   64                          0.806                              0                                   0.220                                  0.018                               0.081   0.347   0.007   0

\*All cultures were performed with an initial concentration of 20 g·l^-1^ of glucose under microaerobic condition. The extracellular metabolite concentrations and yields (g metabolite produced/g glucose consumed) were determined at the time of glucose exhaustion or when the strains ceased to consume glucose. Fermentation time indicates the mean time of the end of fermentation. Residual glucose indicates the amount of glucose detected in the supernatant at the end of fermentation.

\*\* All data correspond to the mean of four independent experiments (n = 4) unless indicated. For all data, standard error of the mean is lower than 10%.

^‡^ Data correspond to the mean of three independent experiments (n = 3).

^†^ Data correspond to the mean of two independent experiments (n = 2).

Previous works stated that acetaldehyde accumulation in Δ*adh1* strain led to poor growth in glucose \[[@B34],[@B35]\]. Acetaldehyde at a level higher than 0.3 g·l^-1^ inhibits cell growth \[[@B36]\]. We found that the concentrations of acetaldehyde in the supernatant at the end of fermentation were significantly higher in deletion strains (B2C-a1, B2C-a1a3, B2C-a1a5 and B2C-a1a3a5) than the wild-type strain (Table [3](#T3){ref-type="table"}). Accordingly, the final biomass yields for these deletion strains were highly reduced. We also thought that perhaps the high acetaldehyde level in the supernatant, which is toxic to the cells, causes the cessation in glucose uptake of some of the deletion strains. In addition, deletion strains also exhibited 22- 71% higher level of acetate and 6 - 8-fold increase in glycerol level over wild-type strain. Analysis of strain lacking *ADH1* or *ADH1-4* isozymes previously has shown that glycerol is the main fermentation product for these strains, while acetaldehyde and acetate are produced in significant amounts \[[@B30]\]. This is because reducing the flux towards ethanol led to the accumulation of NADH and acetaldehyde. Generation of glycerol allows the strain to reoxidize excess NADH in the cytosols, while acetate formation reduces the acetaldehyde accumulated. Nevertheless, 2,3-butanediol production in these strains has not been reported. 2,3-Butanediol can be synthesized directly from pyruvate via yeast innate pathway. Production of 2,3-butanediol requires the oxidation of NADH, whereas oxidation of acetaldehyde to acetate reduced the cofactor NAD(P)^+^. Thus, accumulation of acetaldehyde in strains B2C-a1, B2C-a1a3 and B2C-a1a5 strains greatly increased the production of 2,3-butanediol. The results of additional gene deletion strategies to reduce by-products (acetate and glycerol) and their effect on 2,3-butanediol production are discussed in the next sections.

Production of 2,3-butanediol in the engineered strain mostly occurs through the pathways that are catalyzed by pyruvate decarboxylase. Deletion of *PDC1* from Δ*adh1* background was reported to reduce acetaldehyde production \[[@B37]\]. In our study on Δ*adh1* Δ*pdc1* strain, less than 0.60 g·l^-1^ of 2,3-butanediol was detected (unpublished observations). Deletion of *PDC1* from Δ*adh1* strain reduced the flux towards acetaldehyde and consequently decreased acetoin production. This attested that pyruvate decarboxylase enzyme is important in the production of acetaldehyde and the production of 2,3-butanediol. Nevertheless, the acetoin synthase activity of pyruvate decarboxylase enzyme has been reported to reach saturation level \[[@B5]\] at a very low concentration and increase only by 10% even with larger pool of acetaldehyde. So, further deletion of more ADH genes did not resulted in a more drastic increase in 2,3-butanediol production.

The effect of *ALD6* gene deletion on 2,3-butanediol production
---------------------------------------------------------------

*ALD6* gene encodes the main cytosolic aldehyde dehydrogenase that catalyzes the conversion of acetaldehyde to acetate. Eglinton et al. has shown that acetic acid production can be reduced in glycerol overproducing strain of *S. cerevisiae* by deleting the *ALD6* gene \[[@B38]\]. As discussed in the previous section, strains B2C-a1, B2C-a1a3, B2C-a1a5 and B2C-a1a3a5 produced more acetate when compared to the wild-type strain. High production of acetic acid lowers the pH of the culture broth and can induce programmed cell death in *S. cerevisiae* cells \[[@B39]\]. So, we investigated the effect of *ALD6* deletion on the production of 2,3-butanediol in the engineered strains with deletion in one or more ADH genes.

Deletion of *ALD6* significantly reduced the production of acetate in all the engineered strains, from an average of 0.47 g·l^-1^ to undetectable level (Figure [2](#F2){ref-type="fig"}). However, this decrease in acetate did not correspond to the increase in 2,3-butanediol production in most of the engineered strains. Only strain B2C-a1a6 showed a slight increase in 2,3-butanediol yield when compared to its parent strain (B2C-a1), from 0.041 g·g^-1^ to 0.046 g·g^-1^. On the contrary, the 2,3-butanediol yield of B2C-a1a3a6 was equal to only 30% of strain B2C-a1a3. Similarly, strain B2C-a1a5a6 had a 58% lower 2,3-butanediol yield than strain B2C-a1a5 (Table [3](#T3){ref-type="table"}).

We had initially anticipated that deletion of the aldehyde dehydrogenase gene, *ALD6,* in strains that contained one or more deleted ADH genes would lead to the accumulation of acetaldehyde. This acetaldehyde could then be converted to acetoin through pyruvate decarboxylase reaction and consequently improve 2,3-butanediol yield. In contrast to our initial hypothesis, strains B2C-a1a5a6 and B2C-a1a3a6 yielded higher levels of ethanol and lower levels of acetaldehyde than strains B2C-a1a5 and B2C-a1a3 which harbor the native *ALD6* gene. This suggests an increase in the activity of the remaining ADH isozymes of these mutant strains as a survival mechanism of the cells due to the toxicity of acetaldehyde. These residual ADH isozymes compete more efficiently for acetaldehyde than the acetoin-synthesizing pyruvate decarboxylase, which is another pathway for acetaldehyde detoxification. Similarly, Roustan et al. \[[@B40]\] have reported that the ADH activity of wine yeast increased when acetaldehyde was added to the stationary phase medium of wine fermentation.

The effect of *GPD2* gene deletion on extracellular metabolite yields
---------------------------------------------------------------------

In strains carrying deletion of *ADH1*, excess G3P is produced by G3P dehydrogenase from dihydroxyacetone phosphate while regenerating NAD^+^. Glycerol is then formed by the dephosphorylation reaction of glycerol-3-phosphatase. Two strains (B2C-a1a6 and B2C-a1a3a5) that produced glycerol as the major fermentation product under microaerobic condition were evaluated for the effect of the disruption of G3P dehydrogenase reaction.

*GPD1* and *GPD2* encode the isozymes of G3P dehydrogenase. It has been shown that the deletion of both genes cease glycerol production in *S. cerevisiae* cells \[[@B41]\]. Nevertheless, deletion of both genes was lethal in strain B2C-a1a6 as the cell lost the ability to re-oxidize excess NADH and produce ATP. Single deletion of the osmoregulated *GPD1* in Δ*adh1* Δ*ald6* background has minor effect in the reduction of glycerol production (data not shown). On the contrary, the deletion of *GPD2* in strain B2C-a1a6 reduced glycerol production when compared to the double deletion strain (Figure [3](#F3){ref-type="fig"}). *GPD2* activity is affected by redox control. The limitation in NADH re-oxidation ability due to the deletion of *ADH1* in strain B2C-a1a6, as well as the low oxygen condition during microaerobic cultivation, contributes to the stressful condition where *GPD2* expression is highly induced. The increase in pyruvate and NADH due to *GPD2* deletion, however, did not favor 2,3-butanediol production in strain B2C-a1a6g2 as ethanol became the major fermentation product. Similarly, deletion of both *ALD6* and *GPD2* from strain B2C-a1a3a5 also completely altered the final product composition of the medium. The quintuple deletion strain displayed lower yield of 2,3-butanediol and glycerol, but higher yield of ethanol (Table [3](#T3){ref-type="table"}).

![**The effect of*GPD2*deletion on 2,3-butanediol, glycerol and ethanol yields.** Metabolite yields for strains (a) BY4742, (b) B2C-a1a6, (c) B2C-a1a6g2, (d) B2C-a1a3a5 and (e) B2C-a1a3a5a6g2 at the end of batch cultivation under microaerobic condition. Columns and error bars correspond to the mean value and standard deviations of four independent experiments for (a) and (b), duplicate experiments for (c) and (d) and triplicate experiments for (e).](1475-2859-11-68-3){#F3}

In strains with *ADH1* deletion, glycerol is greatly produced to regenerate the reducing equivalents \[[@B34]\]. By reducing the ability of the cells to oxidize excess NADH through glycerol production, ethanol was again produced as major fermentation product in strains B2C-a1a6g2 and B2C-a1a3a5a6g2. It is possible that the expressions of the remaining ADH genes were induced to cope with the NADH surplus condition. This is because the synthesis of two moles of ethanol from one mole of pyruvate and one mole of acetaldehyde consumes twice the amount of NADH that is required for the formation of one mole of 2,3-butanediol from the same amount of precursor molecules \[[@B40]\].

Anaerobic batch fermentation
----------------------------

In order to test whether 2,3-butanediol production can be improved in a highly fermentative condition, strains B2C-a1a5, B2C-a1a6, B2C-a1a3a5 and wild-type strain BY4742 were selected for anaerobic batch cultivation. In the absence of oxygen, *S. cerevisiae* cells are known to produce significant amount of ethanol and glycerol as a mean to maintain redox balance and generate ATP in the cells. Due to slower growth in anaerobic state, the biomass yield of wild-type and all engineered strains were greatly reduced while the fermentation time increased significantly. All strains exhibited higher glycerol yield due to anaerobiosis. Meanwhile, a decline in the production of the more oxidized acetate was observed in wild-type and the engineered strains (Figure [4](#F4){ref-type="fig"}).

![**Metabolite profile of cultivation under microaerobic (M) and anaerobic (A) conditions.** The bar chart shows glycerol, 2,3-butanediol, ethanol and acetate yields for batch fermentation of (a) BY4742, (b) B2C-a1a5, (c) B2C-a1a6 and (d) B2C-a1a3a5 under microaerobic condition and anaerobic condition with 20 g·l^-1^ of glucose as substrate. Error bars represent standard deviations.](1475-2859-11-68-4){#F4}

With deficiency in its ADH genes, the engineered strains B2C-a1a5, B2C-a1a6 and B2C-a1a3a5 produced glycerol as the major fermentation product. Under microaerobic condition, the second major by-product was ethanol, followed by 2,3-butanediol. Interestingly, growth in anoxic state led to the opposite case for strains B2C-a1a5 and B2C-a1a3a5, where 2,3-butanediol yield was higher than ethanol yield (Figure [4](#F4){ref-type="fig"}). In comparison to the microaerobic state, the yield of ethanol in anaerobic state was lowered by more than 34% and 24% for strains B2C-a1a5 and B2C-a1a3a5, respectively. Up to 2.29 g·l^-1^ of 2,3-butanediol was detected in the fermentation broth for the triple deletion strain, with a yield of 0.113 g·g^-1^ (Figure [5](#F5){ref-type="fig"}). 2,3-Butanediol was not detected in wild-type strain culture broth under anaerobic condition.

![**Changes in metabolite concentrations for strains (a) BY4742 (wild-type) and (b) B2C-a1a3a5 under anaerobic condition.** Glucose (brown circles), OD~660nm~ (black circles), glycerol (inversed triangles), 2,3-butanediol (squares), ethanol (diamonds) and acetate (triangles) concentrations are shown. Symbols and error bars represent the mean and standard deviation for **(a)** triplicate and **(b)** duplicate experiments.](1475-2859-11-68-5){#F5}

An intriguing relationship between the level of oxygen with the production concentration of 2,3-butanediol and ethanol can be deduced from our observation. 2,3-Butanediol yield correlates inversely with the level of oxygen and thus the biomass yield. As low oxygen is known to led to higher fermentative energy metabolism in *S. cerevisiae,* it is not surprising to obtain more fermentation products under anaerobic condition. It is harder to interpret the connection between 2,3-butanediol and ethanol when combined with oxygen level. Since 2,3-butanediol and ethanol shares the same precursor molecule, their concentrations should correlate in an inverse manner. We suspected that the rate of acetaldehyde formation determines the amount of ethanol and 2,3-butanediol produced. However, we could not track the dynamic changes in the concentration of intracellular acetaldehyde in this study.

Improved 2,3-butanediol yield by gene overexpression strategies
---------------------------------------------------------------

In this section, we compared the single overexpression of innate *BDH1* and introduction of additional 2,3-butanediol synthesis pathway from bacteria in three different host: wild-type strain, strain B2C-a1a5 and strain B2C-a1a6. The heterologous pathway was introduced by the co-expression of *B. subtilis alsS* gene, *E. aerogenes budA* gene and *E. aerogenes budC* gene using two multicopy plasmids (Table [4](#T4){ref-type="table"}). We used the acetolactate synthase of *B. subtilis* encoded by *alsS* gene because it has stronger preference for pyruvate over 2-ketobutyrate \[[@B42]\]. On the contrary, *S. cerevisiae* native acetolactate synthase encoded by *ILV2* has higher affinity for 2-ketobutyrate. *E. aerogenes budA* encodes α-acetolactate decarboxylase, which is absent in *S. cerevisiae* strain. The *E. aerogenes* 2,3-butanediol dehydrogenase, encoded by *budC*, displays higher affinity for both NADH and acetoin (K~m,NADH~ = 5--7 μM and K~m,acetoin~ = 0.4 mM) than the *S. cerevisiae* native Bdh1p (K~m,NADH~ = 45 μM and K~m,acetoin~ = 3 mM) \[[@B43],[@B44]\]. The mRNA expression levels of all the genes in the strains we constructed have been confirmed by real-time PCR (data not shown).

###### 

Plasmid used in this study

  **Plasmid**                         **Description**                                                                                                                                                **Reference**
  ----------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------
  pFA6a-KanMX6                        *E. coli kan*^r^ gene under the control of *Ashbya gossypii TEF* promoter-driven                                                                               \[[@B45]\]
  pCNKanMX6                           *loxP* flanking KanMX6 at SalI/BamHI and SacI/EcoRV sites                                                                                                      This study
  pTKURA3                             *loxP* flanking *S. cerevisiae URA3* gene                                                                                                                      This study
  p423GPD                             2 μ, *HIS3*, P~*GPD1*~                                                                                                                                         \[[@B46]\]
  p423TEF                             2 μ, *HIS3*, P~*TEF1*~                                                                                                                                         \[[@B46]\]
  p423GPD-BDH1                        *S. cerevisiae BDH1* gene under the control of *GPD1* promoter in p423GPD                                                                                      This study
  p423TEF-BDH1                        *S. cerevisiae BDH1* gene under the control of *TEF1* promoter in p423GPD                                                                                      This study
  p423GPD-E.a.budC                    *E. aerogenes* KCTC 2190 *budC* gene under the control of *GPD1* promoter in p423GPD                                                                           This study
  pESC-URA                            2 μ, *URA3*, P~*GAL10*~ P~*GAL1*~                                                                                                                              Stratagene
  pESC-LEU                            2 μ, *LEU2*, P~*GAL10*~ P~*GAL1*~                                                                                                                              Stratagene
  pESC-LEU-Cre                        P1 bacteriophage Cre recombinase under the control of *GAL10* promoter                                                                                         This study
  pCTP-URA                            2 μ, URA3, P~*TEF1*~ P~*PGK1*~                                                                                                                                 This study
  pCTP-URA::TEF1p-alsS + PGK1p-budA   *Bacillus subtilis alsS* gene under the control of *TEF1* promoter and *E. aerogenes* KCTC 2190 *budA* gene under the control of *PGK1* promoter in pCTP-URA   This study

In the wild-type strain, overexpression of *BDH1* and the bacterial pathway genes increased 2,3-butanediol yield by 2.4-fold and 11.1-fold, respectively (Figure [6](#F6){ref-type="fig"}). However, the yield of these strains is very low when compared with the deletion strains. The introduction of acetolactate decarboxylase pathway managed to double the yield of 2,3-butanediol in strain B2C-a1a6 to 0.089 g·g^-1^. In the engineered strain B2C-a1a5, 2,3-butanediol yield was only slightly affected by the overexpression of endogenous butanediol dehydrogenase gene. The introduction of the heterologous pathway, however, successfully increased 2,3-butanediol yield by 22% when compared with its parent strain B2C-a1a5. Despite the small enhancement of 2,3-butanediol yield, strain B2C-a1a5-ABC produced the highest titer of 2,3-butanediol, with up to 1.67 g·l^-1^, corresponding to 2,3-butanediol yield of 0.096 g·g^-1^ during microaerobic shake-flask culture.

![**Comparison of 2,3-butanediol yield with gene overexpression strategies.** Each bar represents the 2,3-butanediol yield for shake-flask cultivation under microaerobic condition for three different host strains: (a) BY4742, (b) B2C-a1a5 and (c) B2C-a1a6 expressing . Red bars, host strain (reference); yellow bars, overexpression of *S. cerevisiae* innate *BDH1*; green bars, bacterial *alsS-budA-budC* co-expression. Values and error bars correspond to the mean and standard deviation for triplicate experiments (except for all the red bars, where four independent experiments were conducted)](1475-2859-11-68-6){#F6}

In wild-type strain and strain B2C-a1a5, overexpression of *BDH1* rendered minimal effect on 2,3-butanediol yield. It seems likely that butanediol dehydrogenase reaction is not the bottleneck in 2,3-butanediol biosynthetic pathways in these strains. This is because the flux towards acetoin was probably not adequate in the wild-type strain expressing *BDH1*; whereas in the case of strain B2C-a1a5, it is possible that the conversion of acetaldehyde to acetoin is the rate-limiting step as significant amount of acetaldehyde accumulated in the medium (Table [3](#T3){ref-type="table"}). Strain B2C-a1a6 is the only host strain that demonstrated a greater increase in 2,3-butanediol yield due the amplification of *BDH1*. It is also surprising that this strain yielded more 2,3-butanediol than ethanol (0.0887 g·g^-1^ and 0.0713 g·g^-1^, respectively) when the bacterial pathway genes are introduced. However, this strain (B2C-a1a6-ABC) only managed to consume half of the amount of glucose supplied in the fermentation medium under microaerobic condition implicating that the cell growth was greatly inhibited by certain metabolites or its cellular redox state is highly imbalanced (Data not shown). To enhance the overall flux from pyruvate to 2,3-butanediol in *S. cerevisiae*, our data in this section suggests that the overexpression of *budC or BDH1* together with *alsS* and *budA* can be an alternative to forcing carbon fluxes through the rate-limiting pyruvate decarboxylase pathway.

Conclusions
===========

*In silico S. cerevisiae* strain design for the production of 2,3-butanediol suggested the deletion of mitochondrial and cytosolic ADH genes. We thus constructed deletion strains with low ADH activity by the deletion of *ADH1, ADH3* and *ADH5* genes. Single deletion of major cytosolic ADH gene *ADH1* increased the production titer by around 21-fold. Detoxification mechanism of cells as a response to increased acetaldehyde pool \[[@B8]\], along with the failure to regenerate excess NADH efficiently through ethanol production stimulate 2,3-butanediol production in the deletion strains. Further reduction of ADH activity by additional disruption of *ADH3* or *ADH5* or both genes increased production by \~2-fold when compared to single deletion strain. But distinctively higher production was not observed, showing that the maximal conversion of acetaldehyde to acetoin and subsequently to 2,3-butanediol has been achieved by reducing ADH activity. High accumulation of acetaldehyde in these deletion strains also implies that the conversion of acetaldehyde to acetoin is rate-limiting. We have thus shown that 2,3-butanediol production can be enhanced in the engineered strains through the introduction of foreign biosynthetic pathway. Further improvement of the conversion efficiency of precursor molecules to 2,3-butanediol have to be considered in future study.

OptKnock framework has suggested a deletion strategy that led us to the hypothesis that increase in NADH, acetaldehyde and pyruvate could improve 2,3-butanediol production. This is supported by our data with strains lacking major ADH genes. Nevertheless, this hypothesis is true only to a certain extent as rational deletion strategies based on this hypothesis, including *ALD6* deletion to accumulate acetaldehyde and *GPD2* deletion to further increase NADH and pyruvate in strains with low ADH activity, did not enhance 2,3-butanediol production but increased ethanol formation instead. Problems remained to be solved to further engineer the industrial workhorse *S. cerevisiae* for 2,3-butanediol production.

In conclusion, we have demonstrated a successful implementation of *in silico* guided metabolic engineering approach for the production of a fermentative product in *S. cerevisiae.* 2,3-Butanediol producing *S. cerevisiae* strains were constructed by referring to OptKnock's prediction. Currently, among all the engineered strains, strain B2C-a1a3a5 (*Δadh1* Δ*adh3* Δ*adh5*) achieved the highest 2,3-butanediol titer and yield under anaerobic condition (2.29 g·l^-1^ and 0.113 g·g^-1^). To our knowledge, this is the first ever report about 2,3-butanediol production in *S. cerevisiae* strain specifically engineered for its production.

Methods
=======

Computational procedure
-----------------------

FBA-based simulation and strain design using OptKnock algorithm \[[@B18]\] were performed in Matlab R2010a (The MathWorks, Inc., Massachusetts, USA) with the COBRA Toolbox v2.0 \[[@B47]\]. Gurobi Optimizer 4.5 (Gurobi Optimization, Houston, USA) was used to performed linear programming calculations. The recently reported yeast genome-scale model iMM904 \[[@B13]\], consisting of 904 genes, 1577 reactions and 1228 metabolites, was used. All simulations were performed with the following constraints: oxygen uptake rate, 2mmol·gDCW^-1^·hr^-1^; glucose uptake, 10mmol·gDCW^-1^·hr^-1^; ATP required for maintenance, 1mmol·gDCW^-1^·hr^-1^. We excluded all exchange and transports reactions from the target knockouts.

Strains, plasmid and growth conditions
--------------------------------------

All engineered strains used in this study are derived from *S. cerevisiae* BY4742 strain family (BY4742 *MATα his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0*). During constructions, strains were grown and maintained on complex (YPD) medium consisting of 1% (w/v) bacto yeast extract and 2% (w/v) yeast bacto peptone supplemented with 20 g·l^-1^ glucose as carbon source. Transformants and strains harboring recombinant plasmid(s) were grown on synthetic complete dropout (SC) medium consisted of 20 g·l^-1^ glucose, 6.7 g·l^-1^ yeast nitrogen base without amino acid (Difco, BD Biosciences) and the appropriate amino acid supplement mixture (either CSM, CSM-URA, CSM-HIS, CSM-LEU or CSM-HIS-URA, MP Biomedicals). In all cases, glucose was autoclaved separately. *Escherichia coli* DH5α strain was used for amplification of plasmids. Transformed *E. coli* DH5α cells were grown at 37°C in Luria-Bertani (LB) medium containing 100ug·ml^-1^ of ampicillin.

Construction of *S. cerevisiae* deletion strains
------------------------------------------------

All the strains used in this work are listed in Table [2](#T2){ref-type="table"}. Gene deletion of *S. cerevisiae* was performed by short flanking homology PCR method with Cre/loxP system for recycling of selection marker gene. pCNKanMX6, a plasmid containing *loxP-kanMX-loxP* module, were constructed from pFA6a-KanMX6 according to \[[@B48]\]. pTKURA3 were constructed by replacing the KanMX6 cassette with *S. cerevisiae URA3* gene including 200 nucleotides upstream and +77 nucleotides downstream of *URA3* gene. *ADH1* gene was deleted by introduction of linearized gene deletion cassette consisting of loxP-URA3-loxP sequence flanked by the 45 nucleotides upstream and downstream of *ADH1* gene to BY4742 wild-type strain. *ADH3ADH5* or *ALD6* genes were then deleted in Δ*adh1* background using the same method to construct double gene deletion strains B2C-a1a3, B2C-a1a5 and B2C-a1a6. To construct the triple deletion strains B2C-a1a3a6 and B2C-a1a5a6, *ADH3* and *ADH5* were again deleted separately from Δ*adh1* Δ*ald6* background with the previously described method. Meanwhile, strain B2C-a1a3a5 was constructed by the deletion of *ADH3* from strain B2C-a1a5. Strain B2C-a1a6g2 was constructed by the deletion of *GPD2* gene from strain B2C-a1a6. Further deletion of *ADH3* and *ADH5* genes from strain B2C-a1a6g2 resulted in the quintuple deletion strain B2C-a1a6g2a3a5. All strains were verified by colony polymerase chain reaction (PCR) with appropriate confirmation primers (Additional file [2](#S2){ref-type="supplementary-material"}). The aragose gel images of all gene deletion strains are provided (Additional file [3](#S3){ref-type="supplementary-material"}).

Plasmid construction and transformation
---------------------------------------

The plasmids used in this study are listed in Table [4](#T4){ref-type="table"}. *S. cerevisiae BDH1* gene was amplified from the genomic DNA of BY4742 strain with the primers BDH1-F-BamHI and BDH1-R-XhoI. The fragment amplified was ligated to p423GPD and p423TEF that were digested with BamHI and XhoI. The resulting construct is p423GPD-BDH1 and p423TEF-BDH1. *E. aerogenes budC* gene was amplified from the genomic DNA of *E. aerogenes* KCTC 2190 strain by PCR using the primers E.a.budC-F-BamHI and E.a.budC-R-EcoRV. *budC* gene fragment was then inserted between the BamHI-EcoRV sites of p423GPD, resulting in p423GPD-E.a.budC.

The *GAL1*/*GAL10* promoter regions of pESC-URA(Stratagene) were removed and replaced with the *PGK1*/*TEF1* divergent promoters by two-step cloning. *PGK1* promoter sequence was amplified from the genomic DNA of *S. cerevisiae* BY4742 wild-type strain with primers PGK1p-F-AatII-NotI and PGK1p-R-BamHI. It was then digested with BamHI and NotI and cloned into pESC-URA to produce pCP-URA. *TEF1* promoter region was amplified from p425TEF with primers TEF1p-R-NotI and TEF1p-F-AatII. The *TEF1* promoter fragment and pCP-URA were digested by AatII and NotI and then ligated to each other. The new plasmid generated is pCTP-URA. *Bacillus subtilis alsS* gene was amplified from the genomic DNA of *B. subtilis* using primers B.s.alsS-F-NotI and B.s.alsS-R-BglII. Meanwhile, *E. aerogenes budA* was amplified from the genomic DNA of *E. aerogenes* KCTC 2190 strain with primers E.a.budA-F-BamHI and E.a.budA-R-XhoI. *B. subtilis alsS* and *E. aerogenes budA* fragment were cloned into pCTP-URA under the control of *TEF1* promoter and *PGK1* promoter, respectively.

In all cases, PCR was performed using TaKaRa LA Taq Polymerase with GC Buffer (Takara Bio Inc, Shiga, Japan). Yeast strains were transformed using the lithium acetate/PEG/SS-DNA method \[[@B49]\]. After transformation, successful transformants were selected on SC media without the appropriate amino acids.

Batch fermentations
-------------------

For all fermentations, pre-cultures were prepared by inoculating 5 ml of SC medium in a 50 ml screw-capped tube with a fresh colony grown on solid medium. Batch fermentations were performed in 250 ml Erlenmeyer flasks containing 50 ml of synthetic complete dropout medium. Microaerobic condition was maintained in the flasks by sealing with rubber stoppers. For anaerobic fermentations, 50 ml of SC medium supplemented with 0.42 g·l^-1^ Tween 80 and 0.01 g·l^-1^ cholesterol in a 150 ml serum bottle was purged with pure nitrogen gas for 15 minutes to establish anaerobic condition. Initial OD~660nm~ was adjusted at 0.05. Fermentations were performed in shaking incubator at 30°C, with agitation at 250 rpm.

Analytical methods
------------------

Cell growth was determined by measuring the absorbance at 660 nm using UV--VIS spectrophotometer (Shimazu UV mini 1240, Tokyo, Japan). In addition, we determined the dry cell mass of yeast at the end of shake-flask cultivation by filtering 30 ml of culture through pre-weighed cellulose acetate membrane filters (Chmlab Group, Barcelona, Spain) with a pore size of 0.45 μm. Filters were dried at 65°C for 48 hours and weighed again. Then, we calculated the dry cell mass and estimated the cell biomass by using the dry cell mass/OD660 ratio at the end of cultivation.

For extracellular metabolite analysis, 1 ml of culture samples were collected at appropriate time point. Isopropyl alcohol was added to the 1 ml-sample as internal standard and vortexed for 1 min. The samples were then centrifuged (13500 rpm, 5 min) and 200 μl of supernatants were transferred to HPLC autosampler vials. Extracellular concentrations of glucose, glycerol, ethanol, acetate, succinate, acetoin and 2,3-butanediol were determined with a high performance liquid chromatography (HPLC) system (ACME-9000, Younglin Instrument, Seoul, South Korea) equipped with a refractive index detector (RID). Analytes were separated using Sugar SH1011 column (Shodex, Tokyo, Japan) with 10 mM sulfuric acid as mobile phase pumped at 0.5ml·min^-1^. The column and the detector were set to 75°C and 45°C, respectively. The order of elution was glucose, succinic acid, glycerol, acetate, acetoin, 2,3-butanediol, ethanol and isopropyl alcohol. For quantitative analysis, standards for all metabolite at five different concentration levels were prepared. A calibration curve for each component was made and from these calibration curves concentrations of metabolites were calculated. The standard for 2,3-butanediol (≥99.0% (GC), Fluka Analytical, Sigma-Aldrich) and the extracellular 2,3-butanediol from the fermentation samples are a mixture of racemic and meso forms. Extracellular acetaldehyde concentrations were determined with Megazyme Acetaldehyde Assay Kit (Megazyme International Ireland, Wicklow, Ireland) according to the manufacturer's instructions.
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